World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
23083
World Ranking
17558
National Ranking
661

Overview

Hanneke C. Kluin-Nelemans is affiliated with the University Medical Center Groningen in the Netherlands. Their research activity focuses predominantly within the field of Medicine, specifically engaging with Immunology, Pathology and Forensic Medicine, Immunology and Allergy, Physiology, and Oncology.

Their work largely investigates topics such as Lymphoma Diagnosis and Treatment, Mast Cells and Histamine, Asthma and Respiratory Diseases, Urticaria and Related Conditions, Viral-Associated Cancers and Disorders, Chronic Lymphocytic Leukemia Research, and Food Allergy and Anaphylaxis Research.

Frequent publication venues for Hanneke C. Kluin-Nelemans include The Journal of Allergy and Clinical Immunology In Practice, Blood, Blood Advances, Journal of Allergy and Clinical Immunology, and Leukemia.

Frequent co-authors collaborating in their research are Olivier Hermine, Peter Valent, Karin Hartmann, Andreas Reiter, and Jason Gotlib.

Recent papers authored or co-authored by Hanneke C. Kluin-Nelemans include:

  • Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal (2021, HemaSphere)
  • Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts (2020, Theranostics)
  • Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium (2022, The Journal of Allergy and Clinical Immunology In Practice)
  • Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification (2020, Allergy)
  • Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis (2020, Journal of Allergy and Clinical Immunology)

Best Publications

  • A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

    Eva Hoster;Martin Dreyling;Wolfram Klapper;Christian Gisselbrecht

  • Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.

    P. Valent;C. Akin;L. Escribano;M. Födinger

  • Double-hit B-cell lymphomas

    Sietse M. Aukema;Reiner Siebert;Ed Schuuring;Gustaaf W. van Imhoff

  • Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network

    Martin Dreyling;Georg Lenz;Eva Hoster;Achiel Van Hoof

  • Morbidity and mortality in adults with idiopathic thrombocytopenic purpura

    Johanna E. A. Portielje;Rudi G. J. Westendorp;Hanneke C. Kluin-Nelemans;Anneke Brand

  • Treatment of Older Patients with Mantle-Cell Lymphoma

    H. C. Kluin-Nelemans;Eva Hoster;Olivier Hermine;J. Walewski

  • Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis

    Jason Gotlib;Hanneke C. Kluin-Nelemans;Tracy I. George;Cem Akin

  • Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders

    Francesca Bonifazi;Antonio de Vivo;Gianantonio Rosti;François Guilhot

  • High-Dose Methotrexate-Based Chemotherapy Followed by Consolidating Radiotherapy in Non–AIDS-Related Primary Central Nervous System Lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962

    Philip M.P. Poortmans;Hanneke C. Kluin-Nelemans;Hanny Haaxma-Reiche;Mars Van’t Veer

  • Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology

    Karin Hartmann;Luis Escribano;Clive Grattan;Knut Brockow

  • Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes.

    J.H. Frederik Falkenburg;Amon R. Wafelman;Peter Joosten;Willem M. Smit

  • Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma

    L F Verdonck;W L van Putten;A Hagenbeek;H C Schouten

  • KIT mutation analysis in mast cell neoplasms : recommendations of the European Competence Network on Mastocytosis

    Michel Arock;Karl Sotlar;Cem Akin;Sigurd Broesby-Olsen

  • The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma.

    Hein P. J. Visser;Marco J. Gunster;Hanneke C. Kluin-Nelemans;Erik M. M. Manders

  • Cladribine therapy for systemic mastocytosis

    Hanneke C Kluin-Nelemans;J Marja Oldhoff;Jasper J Van Doormaal;Jan W Van 't Wout

  • Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study.

    Christiane Pott;Eva Hoster;Marie-Helene Delfau-Larue;Kheira Beldjord

  • Response to interferon alfa-2b in a patient with systemic mastocytosis.

    Hanneke C. Kluin-Nelemans;Joop H. Jansen;Henk Breukelman;Bert G Wolthers

  • Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future

    Peter Valent;Cem Akin;Karin Hartmann;Gunnar Nilsson

  • Inhibition of human macrophage colony formation by interleukin 4.

    J. H. Jansen;G.-J. H. M. Wientjens;W. E. Fibbe;R. Willemze

  • Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma

    M P Purdue;Q Lan;T J Kemp;A Hildesheim

Frequent Co-Authors

Olivier Hermine
Olivier Hermine Necker-Enfants Malades Hospital
Peter Valent
Peter Valent Medical University of Vienna
Karin Hartmann
Karin Hartmann University Hospital of Basel
Andreas Reiter
Andreas Reiter Heidelberg University
Jason Gotlib
Jason Gotlib Stanford University
Martin Dreyling
Martin Dreyling Ludwig-Maximilians-Universität München
Massimo Triggiani
Massimo Triggiani University of Salerno
Cem Akin
Cem Akin University of Michigan–Ann Arbor
Knut Brockow
Knut Brockow Technical University of Munich
Wolfram Klapper
Wolfram Klapper Kiel University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare but not sure if a traditional medical degree is the right fit? There are many medical billing and coding online courses cost options that provide entry into the health sector without spending years in medical school. Online programs are flexible and often more affordable, making them ideal for working adults or career-changers.

Nursing is one of the most popular alternative pathways. If you're looking to advance your career, consider the cheapest online nurse practitioner programs or explore cheap online nursing programs for undergraduate and graduate degrees. These programs prepare graduates for high-demand roles in hospitals, clinics, and community health.

For those seeking leadership, research, or teaching roles, an online phd in nursing opens doors to the highest level of expertise in the field. Online education can help you achieve healthcare career goals while maintaining work-life balance and managing educational expenses.

Best Scientists Citing Hanneke C. Kluin-Nelemans

Trending Scientists